Growing up with chronic renal failure.

1 Rustin GJS. Tumour markers in germ cell tumours. BrMedJ 1986;292:7134. 2 Lucraft HH. A review of thirty-three cases of ovarian dysgerminoma emphasising the role of radiotherapy. Clin Radiol 1979;30:585-9. 3 Gordon A, Lipton D, Woodruff JD. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Regstry. Obstet Gynecol 1981;58:497-504. 4 Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumours of the ovary. Cancer 1985;56:243-8. 5 Taylor MG, Deptrillo AD, Turner AR. Vinblastine, bleomycin, and cisplatin in nmlignant germ cell tumours of the ovary. Cancer 1985;56:1341-9. 6 Newlands ES, Bagshawe KD. Advances in the treatment of germ ceil tumours of the ovary. In: Bonnar J, ed. Recent advances in obstetrics and ynaecology. Edinburgh: Churchill Livingstone, 1987:143-56. 7 Smales E, Peckham MJ. Chemotherapy of germ-cell ovarian tumours: first line treatrnent with etoposide, bleomycin and cisplatin or carboplatin. EurJ7 Cancer Clin Ocol 1987;23:469-74. 8 Gershenson DM, Wharton T, Kline RC, Larson DM, Kavanagh JJ, Rutledge FN. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Cancer 1987;58:2594-9. 9 Pektasides D, Rustin GJS, Newlands ES, Begent RHJ, Bagshawe KD. Fertility after chemotherapy for ovarian germ cell tumours. Bry Obstet Gynaecol 1987;94:477-9. 10 Williams SD, Birch R, Einhom LH, Irwin L, Grego FA, Loehrer PJ. Treatment ofdisseminated germ-cell tumours with cisplatin, bleomycin, and either vinblastine or etoposide. NEnglJ Med 1987;316:1435-40.